Bullish
AgomAb Therapeutics (AGMB) Wins U.S. Patent for AGMB-447
AgomAb Therapeutics NV (NASDAQ:AGMB) secured a U.S. patent for its investigational drug AGMB-447, an ALK5 inhibitor for idiopathic pulmonary fibrosis,...
AGMB
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (1)
Neutral (0)
Bearish (0)
Latest AGMB News
Bullish
Research AGMB on:
Ad Space